Development of thermosensitive liposomes with the help of ML8500

Customer case

Pharmaceutical Nanotechnology Group at University of Helsinki is specialized in top-level pharmaceutical research. Led by Professor Timo Laaksonen, the group focuses on controlled drug release and delivery using modern methods and materials. Particular interest lies in using light to both monitor nanomaterial behavior and to trigger e.g. drug release processes.

Modulight products: ML8500, ML6600, MLAKIT

 

Laser use: Light-triggered drug release studies from light-activated liposomes. ML8500 with 808 nm wavelength was used to induce the release of calcein from liposomes under different temperatures. The effect of different type of lipids on liposomal release properties was investigated.

Link to the study:

 

 

Background

The proper delivery and release of therapeutic drugs to a specific site or cell type is one of the main challenges in the treatment of diseases. Liposomes, which are vesicles composed of lipids, serve as carriers for drug delivery thanks to their long circulation time. This results to reduced toxicity in healthy tissues and improved therapeutic efficacy of encapsulated drugs. However, conventional liposomes can often be even too stabile, leading to insufficient drug release at the target site. Light activation can offer a solution for this dilemma to achieve both sufficient stability and efficient drug release.

Laser light is used to release liposomal contents at the target site, offering time- and site-specific control for the drug release. For this purpose, stimuli-responsive molecules, such as clinically approved indocyanine green, are attached to the liposomal surface, generating heat upon to near-infrared light irradiation leading to the rapid release of liposomal contents. In addition, positively charged (cationic) liposomes can offer better drug uptake by tumor cells, since cancer cells typically have slightly higher negative surface charge because of a higher rate of glycolysis.

 

Professor Timo Laaksonen on liposome research and the role of Modulight ML8500:

 

Study execution

The purpose of the study was to determine optimal lipid composition for light-triggered drug release. Calcein was used as a cargo molecule inside liposomes since its fluorescence could be used to determine the amount of released calcein. The ICG and calcein-loaded cationic liposomes were fabricated via a thin film hydration method. Calcein release from liposomes after light activation was studied using ML8500 automated biomedical illumination instrument. The effect of several different lipids on liposomal leakiness, stability, and light-induced release was investigated.

 

Results

 

Unsaturated lipids (DOTAP) in the liposomal structure caused kink formations and resulted in fluid lipid bilayer. These liposomes were very leaky and calcein release happened already at 32 °C without light activation.

Reproduced from Gangurde et al. under CC BY 4.0 License.

 

In contrast, liposomes with cholesterol in the lipid bilayer made liposomes sturdy and significantly decreased fluidity of liposomes. It also made liposomes unresponsive to light, as liposomes did not release calcein even when temperature reached 50 °C after light activation with the ML8500.

Reproduced from Gangurde et al. under CC BY 4.0 License.

 

The most optimal thermosensitive liposome composition was achieved with saturated lipids (DPTAP), resulting in ordered lipid bilayer and stable liposomes at body temperature (37 °C). Importantly, liposome contents were successfully released after light activation by the ML8500.

Reproduced from Gangurde et al. under CC BY 4.0 License.

 

Conclusions:
Robust and stable thermosensitive cationic liposomes were successfully developed for rapid light-induced drug release. Optimal lipid composition was characterized using ML8500 illumination system. The liposomal system developed here has numerous potential applications in the delivery of therapeutic agents, particularly for anticancer therapy. The ability to release drugs only when and where necessary can minimize the risk of side effects and maximize the efficacy of the treatment. In addition, negative charge of the manufactured liposomes can improve drug uptake in the tumors.

 

Related Modulight products and Services

 

Related Publications

Development of Robust Cationic Light-Activated Thermosensitive Liposomes: Choosing the Right Lipids
Puja Gangurde, Mohammad Mahmoudzadeh, Zahra Gounani, Artturi Koivuniemi, Patrick Laurén, Tatu Lajunen, and Timo Laaksonen
Mol. Pharmaceutics, 2023, 20, 11, 57285738

 

The effect of light sensitizer localization on the stability of indocyanine green liposomes
Tatu Lajunen, Riikka Nurmi, Danny Wilbie, Teemu Ruoslahti, Niklas G. Johansson, Ossi Korhonen, Tomasz Rog, Marika Ruponen, Arto Urtti
 Journal of Controlled Release, 2018, 284

 

 

Contact Us

Do you have questions or comments related to this application note? Maybe you would like to request literature? Or would you like us to feature your research? Please drop us a line!

    First name *

    Family name *

    Company or affiliation *